Skip to main content
Clinical Trials/ACTRN12605000704695
ACTRN12605000704695CompletedPhase 3

The effects of early parenteral nutrition compared to standard care on 60 day landmark mortality in the critically ill patient: A level I randomisedcontrolled trial.

niversity of Sydney0 sites1,470 target enrollmentStarted: November 2, 2005Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
1,470

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
ot stated to ot stated (—)
Sex
All

Inclusion Criteria

  • Patients will be screened for eligibility as soon as practical after admission to the study ICU. Patients will be considered eligible for the trial if the following criteria are addressed at the time of screening: The patient is not currently receiving oral, enteral or parenteral nutritional support; The treating physician does not expect to begin oral, enteral or parenteral nutritional support within 24 hours.

Exclusion Criteria

  • The treating physician expects to discharge the patient from the ICU within 24 hours; The patient's ICU length of stay at time of screening is greater than 24 hours; Parenteral nutrition cannot be started within 24 hours of ICU admission; There is an absolute contraindication for enteral nutrition and the patient would normally be supported with parenteral nutrition (Ex. The patient receives chronic home PN); The patient is admitted to the ICU for treatment of thermal injury (burns); The patient is admitted to the ICU for palliative care; The patient is moribund and not expected to survive 24 hours; The patient is brain dead or suspected to be brain dead; The patient was admitted to the study ICU directly from another ICU; The treating physician believes there is an absolute contraindication to treatment received in either study arm.

Investigators

Similar Trials